These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4342181)

  • 1. Metabolic controls in precancerous liver. II. Loss of feedback control of cholesterol synthesis, measured repeatedly in vivo, during treatment with the carcinogens N-2-fluorenylacetamide and aflatoxin.
    Horton BJ; Horton JD; Sabine JR
    Eur J Cancer (1965); 1972 Aug; 8(4):437-43. PubMed ID: 4342181
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic controls in precancerous liver: defective control of cholesterol synthesis in rats fed N-2-fluorenylacetamide.
    Horton BJ; Sabine JR
    Eur J Cancer (1965); 1971 Oct; 7(5):459-65. PubMed ID: 4334170
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of cholesterol biosynthesis in rat liver after the administration of N-2-fluorenylacetamide.
    Calandra S; Guariento D; Rivasi F
    Lab Invest; 1973 Jun; 28(6):723-7. PubMed ID: 4351645
    [No Abstract]   [Full Text] [Related]  

  • 4. Early elevation of alpha 1-fetoprotein in N-2-fluorenylacetamide hepatocarcinogenesis.
    Becker FF; Sell S
    Cancer Res; 1974 Oct; 34(10):2489-94. PubMed ID: 4412886
    [No Abstract]   [Full Text] [Related]  

  • 5. Specificity of chemical modification of ribonucleic acid transport by liver carcinogens in the rat.
    Shearer RW
    Biochemistry; 1974 Apr; 13(8):1764-7. PubMed ID: 4364710
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of trypan blue on hepatocarcinogenesis in rats given ethionine or N-2-fluorenylacetamide.
    Ito N; Farber E
    J Natl Cancer Inst; 1966 Dec; 37(6):775-85. PubMed ID: 4289069
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic controls in precancerous liver. 3. Further studies on the control of lipid synthesis during N-2-fluorenylacetamide feeding.
    Horton BJ; Sabine JR
    Eur J Cancer (1965); 1973 Jan; 9(1):1-9. PubMed ID: 4703686
    [No Abstract]   [Full Text] [Related]  

  • 8. Altered and distorted DNA from a premalignant liver lesion induced by 2-fluorenylacetamide.
    Epstein SM; Benedetti EL; Shinozuka H; Bartus B; Farber E
    Chem Biol Interact; 1969 Oct; 1(1):113-24. PubMed ID: 5407051
    [No Abstract]   [Full Text] [Related]  

  • 9. Importance of testes in induction of hyperplastic nodules, carcinomas, and cirrhosis of liver in A times C male rats ingesting 0.025 percent N-2-fluorenyldiacetamide.
    Reuber MD
    J Natl Cancer Inst; 1974 Sep; 53(3):883-6. PubMed ID: 4370092
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic controls in precancerous liver. V. Loss of control of cholesterol synthesis during feeding of the hepatocarcinogen 3'-methyl-4-dimethylaminoazobenzene.
    Horton BJ; Horton JD; Sabine JR
    Eur J Cancer (1965); 1973 Aug; 9(8):573-6. PubMed ID: 4207640
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic cell loss and proliferation induced by N-2-fluorenylacetamide, diethylnitrosamine, and aflatoxin B1 in relation to hepatoma induction.
    Nishizumi M; Albert RE; Burns FJ; Bilger L
    Br J Cancer; 1977 Aug; 36(2):192-7. PubMed ID: 199226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation by chemical carcinogens of gamma-glutamyl transpeptidase in rat and mouse liver.
    Fiala S; Fiala ES
    J Natl Cancer Inst; 1973 Jul; 51(1):151-8. PubMed ID: 4146459
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell loss and proliferation induced by N-2-fluorenylacetamide in the rat liver in relation to hepatoma induction.
    Albert RE; Burns FJ; Bilger L; Gardner D; Troll W
    Cancer Res; 1972 Oct; 32(10):2172-7. PubMed ID: 4343011
    [No Abstract]   [Full Text] [Related]  

  • 14. Chromosome patterns in rat hepatocytes during N-2-fluorenylacetamide carcinogenesis.
    Becker FF; Fox RA; Klein KM; Wolman SR
    J Natl Cancer Inst; 1971 Jun; 46(6):1261-9. PubMed ID: 4325934
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylation of transfer RNA and of ribosomal RNA in rat liver in the intact animal and the effect of carcinogens.
    Craddock VM
    Biochim Biophys Acta; 1969 Dec; 195(2):351-69. PubMed ID: 4312611
    [No Abstract]   [Full Text] [Related]  

  • 16. Carcinogenic effect of N-hydroxy-N-2-fluorenylacetamide, 2',4'-dimethylacetanilide, and 2',4'6'-trimethylacetanilide on liver in suckling mice.
    Klein M; Weisburger EK
    Proc Soc Exp Biol Med; 1966 May; 122(1):111-4. PubMed ID: 4287652
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitory effect of polychlorinated biphenyls on liver tumorigenesis in rats treated with 3'-methyl-4-dimethylaminoazobenzene, n-2-fluorenylacetamide, and diethylnitrosamine.
    Makiura S; Aoe H; Sugihara S; Hirao K; Arai M
    J Natl Cancer Inst; 1974 Nov; 53(5):1253-7. PubMed ID: 4372378
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of the carcinogen N-acetoxy-2-fluorenylacetamide on the template properties of deoxyribonucleic acid.
    Zieve FJ
    Mol Pharmacol; 1973 Sep; 9(5):658-69. PubMed ID: 4363017
    [No Abstract]   [Full Text] [Related]  

  • 19. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis.
    Stout DL; Becker FF
    Cancer Res; 1978 Aug; 38(8):2274-8. PubMed ID: 208764
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid uptake of dietary cholesterol by hyperplastic liver nodules and primary hepatomas.
    Horton BJ; Mott GE; Pitot HC; Goldarb S
    Cancer Res; 1973 Mar; 33(3):460-4. PubMed ID: 4347713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.